Lyell Immunopharma, Inc. Earnings Per Share, Basic in USD/shares from 2019 to Q3 2025

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary
Lyell Immunopharma, Inc. quarterly/annual Earnings Per Share, Basic history and growth rate from 2019 to Q3 2025.
  • Lyell Immunopharma, Inc. Earnings Per Share, Basic for the quarter ending September 30, 2025 was -2.13 USD/shares, a 38.8% increase year-over-year.
  • Lyell Immunopharma, Inc. Earnings Per Share, Basic for the twelve months ending September 30, 2025 was 0 USD/shares.
  • Lyell Immunopharma, Inc. annual Earnings Per Share, Basic for 2024 was -1.31 USD/shares, a 40.9% decline from 2023.
  • Lyell Immunopharma, Inc. annual Earnings Per Share, Basic for 2023 was -0.93 USD/shares, a 25.7% decline from 2022.
  • Lyell Immunopharma, Inc. annual Earnings Per Share, Basic for 2022 was -0.74 USD/shares, a 59.8% increase from 2021.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Quarterly (USD/shares)
Earnings Per Share, Basic, YoY Quarterly Growth (%)
Earnings Per Share, Basic, Annual (USD/shares)
Earnings Per Share, Basic, YoY Annual Growth (%)

Lyell Immunopharma, Inc. Quarterly Earnings Per Share, Basic (USD/shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $0 -$2 +$1.35 +38.8% Jul 1, 2025 Sep 30, 2025 10-Q 2025-11-12
Q2 2025 $0 -$3 +$0.70 +19.5% Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-12
Q1 2025 -$1 $0 +$0.06 +25% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-13
Q4 2024 -$1 $6.00 +$6.20 Oct 1, 2024 Dec 31, 2024 10-K 2025-03-11
Q3 2024 -$7 -$3 -$3 -1640% Jul 1, 2024 Sep 30, 2024 10-Q 2025-11-12
Q2 2024 -$4 -$4 -$3 -1281% Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-12
Q1 2024 $0 $0 +$0.03 +11.1% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-13
Q4 2023 $0 $0 $0 -567% Oct 1, 2023 Dec 31, 2023 10-K 2025-03-11
Q3 2023 $0 $0 +$0.08 +28.6% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 $0 $0 $0 -73.3% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-07
Q1 2023 $0 $0 +$0.01 +3.57% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-06
Q4 2022 $0 $0 -$3 -101% Oct 1, 2022 Dec 31, 2022 10-K 2025-03-11
Q3 2022 $2.00 $0 $0 -40% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 $2.00 $0 +$1.32 +89.8% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 $1.00 $0 +$2.91 +91.2% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 -$1 $3.02 Oct 1, 2021 Dec 31, 2021 10-K 2024-02-28
Q3 2021 $0 Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 -$1 Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 -$3 Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10

Lyell Immunopharma, Inc. Annual Earnings Per Share, Basic (USD/shares)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$1 $0 -40.9% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-11
2023 -$1 $0 -25.7% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-11
2022 -$1 +$1.10 +59.8% Jan 1, 2022 Dec 31, 2022 10-K 2025-03-11
2021 -$2 +$13.90 +88.3% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-28
2020 -$16 +$8.35 +34.7% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-28
2019 -$24 Jan 1, 2019 Dec 31, 2019 10-K 2022-03-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.